Developer docs
API playgroundTry for free, no card

Search company profiles

Compound

Full company profile

uuid0000crk

Namestring
Compound
Legal namestring
Compound
Websiteurl
compound.vc
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Compound is a thesis-driven, research-centric venture capital firm founded in 2016 and headquartered at 414 Broadway, New York. The firm invests across six explicit thesis categories—AI/ML, Healthcare, Bio, Robotics, Crypto, and Other—and targets technical founders who require both capital and credible domain engagement. Its 11-person team comprises Managing Partner Michael Dempsey, General Partner David Hirsch, CFO Tara Eckert, Partners 0xSmac and Shelby Newsad, Researcher Mackenzie Morehead, and five Venture Partners covering computational biology, data science & AI, biology, crypto, and AI & robotics.

Compound's core offering is research-driven deal-making, publicised through a Notion-hosted Thesis Database of 100+ investment theses and a content engine spanning the Compound Writing page, CompoundArxiv on Twitter/X, Substack newsletters, and a dedicated crypto sub-site (crypto.compound.vc). The firm uses this corpus as both internal investment framework and external marketing surface, positioning itself to attract founders whose work aligns with pre-published theses. Its business model is that of a small venture fund: economics flow from management fees and carried interest on invested capital, with deal flow sourced from public theses, syndication networks, and direct founder outreach.

Disclosed portfolio activity includes co-investments in SuppCo ($5.5M seed, October 2024) alongside Union Square Ventures, True Ventures, and Box Group; Cycles ($6.4M seed, May 2026) alongside Blockchange Ventures, Coinbase Ventures, and Primitive Ventures; and Orbital Industries ($50M Series B, May 2026) alongside Plural, NVentures (NVIDIA), Radical Ventures, and Fly Ventures. In 2026 the firm extended its research ethos outward via Compound Reverie Grants, a non-dilutive micro-grant program offering $500–$7,500 to researchers in machine learning, robotics, biology, healthcare, energy, and crypto. No firm-level AUM, fund size, or revenue figures are disclosed.

Short descriptiontext

Compound is a New York-based, thesis-driven venture capital firm investing across AI/ML, biology, crypto, and robotics. It serves technical founders with capital and specialist Venture Partner support, publishes 100+ public investment theses, and operates a non-dilutive micro-grants program.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
thesis-driven venture capital, deep tech investing, early-stage startup funding, crypto venture capital, biology biotech investing
Industry2 codes
PRIMARYFSANAAAB
Early-Stage Venture Capital (Series A/B)
SECONDARYFSANAJAN
SDG / Thematic Sustainable Investment Funds
Financial & Insurance/Private Equity & Venture Capital/Impact / ESG & Sustainable Investment Funds
NAICS code2 codes
  • Other Investment Pools and Funds5259
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Investment fund returns
TypeManaged Services
Description

As a thesis-driven venture investment firm, Compound generates economic returns (and fund-level revenue) through capital deployment into portfolio companies and co-investments alongside other investors. Specific fund economics (management fees, carried interest) are not publicly disclosed.

2Reverie Grants program (outbound capital)
TypeProfessional Services
Description

Outbound grant capital of $500 to $7,500 to researchers in cryonics, life extension, AGI safety, mind uploading; not a revenue stream but a capital deployment activity tied to thesis exploration.

Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Pricing details1 tier
1Reverie Grants ($500 - $7,500)
ModelOtherBilling cadencePay-as-you-go
Notes

Grants to individual researchers in cryonics, life extension, AGI safety, and mind uploading. Not a product pricing model.

GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1Compound Reverie Grants
Description

Micro-grants program offering $500–$7,500 in non-dilutive funding for exploratory, thesis-aligned and transitional projects.

compound.vc
+1 more record
Core offering1 text field

Compound is a thesis-driven, research-centric venture capital investment firm that deploys capital into early-stage companies across six categories (AI/ML, Healthcare, Biology, Robotics, Crypto, and Other). It supports founders with domain expertise from specialist Venture Partners, publishes 100+ public investment theses via its Thesis Database and Writing platform, and operates the Compound Reverie Grants micro-grant program ($500–$7,500) for thesis-aligned and transitional researchers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 100+ public theses published across 6 categories since 2016
+2 more records
Product overview1 text field

Compound operates as a unified thesis-driven, research-centric investment firm rather than a traditional multi-product software platform; its public surface area consists of seven interconnected web properties that together form the firm's offering: the Compound Home landing page introducing the firm; the About Us team and mission page; the public Portfolio showcase across Automation (AI/ML/Robotics), Healthcare & Biology, Crypto, and Other categories; the Writing publication platform with essays authored by team members; the standalone Compound Thesis Database of 100 publicly available theses across six categories; the Compound Reverie Grants micro-grant program providing non-dilutive funding to edge-of-thesis explorers; and the Compound Crypto sub-site at crypto.compound.vc for crypto-focused content. The modules fit together as a stack in which the Home/About pages anchor the firm's positioning, the Portfolio demonstrates execution on those beliefs, the Writing and Thesis Database publish the underlying research, the Crypto sub-site drills into one of the six thesis categories, and Reverie Grants extends the firm's research ethos outward to non-venture grantees.

Product and service2 records
1Compound Reverie Grants
CategoryMicro-grant program
Description

Micro-grant program offering non-dilutive, no-strings-attached funding of $500 to $7,500 to individual researchers and transitional thinkers exploring ideas at the edges of the firm's thesis areas, including machine learning, robotics, biology, healthcare, energy, crypto, cryonics, life extension, AGI safety, and mind uploading.

2Thesis-Driven Venture Capital Investment
CategoryVenture capital investment services
Description

Capital deployment into early-stage companies across six thesis categories (AI/ML, Healthcare, Biology, Robotics, Crypto, Other), paired with technical co-building from specialist Venture Partners who help founders solve technical problems, communicate breakthroughs, and scale commercialization.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Paradigm
TypeDirect peer
Description

Paradigm is a thesis-driven crypto/web3-focused investment firm that publishes research and operates with deep domain expertise. It is the closest comparable to Compound's crypto thesis-led, research-publishing model and overlapping crypto portfolio (e.g., investments in Arbitrum-adjacent infrastructure).

TypeDirect peer
Description

Lux Capital is a thesis-driven deep-tech VC investing in AI, robotics, biology, and frontier science with published research and a specialist partner model. It is directly comparable to Compound's bio/AI/robotics thesis-led approach and emphasis on scientifically deep founders.

TypeDirect peer
Description

DCVC (Data Collective) is a thesis-driven deep-tech VC that publishes deep research and invests in computational biology, AI, and engineering biology. It mirrors Compound's six-category, science-first thesis approach and its co-investor posture alongside tier-1 VCs.

TypeEmerging player
Description

Outset Capital is an emerging thesis-driven, research-publishing AI investment firm. It overlaps with Compound's AI/ML & Robotics thesis category and similarly publishes public research as a deal-sourcing and brand-building tool, though at an earlier stage.

TypeBroad incumbent
Description

Founders Fund is a thesis-driven, broad-spectrum VC that publishes essays and bold theses to attract founders. It is comparable to Compound as a thesis-led, content-forward investment firm, but at a much larger scale and across a wider category set.

TypeBroad incumbent
Description

a16z is a broad incumbent thesis-driven VC with a dedicated crypto fund (a16z crypto) that publishes extensive research and operates large grant programs. It overlaps with Compound's crypto thesis category and content-led GTM, but at vastly greater scale and with a multi-stage, multi-product platform.

TypeBroad incumbent
Description

USV is a thesis-driven VC investing across crypto, consumer, and frontier tech, and is a confirmed co-investor with Compound (led SuppCo). It is comparable as a fellow thesis-led, content-publishing VC firm that participates in similar categories like crypto and consumer health.

TypeBroad incumbent
Description

True Ventures is a thesis-driven seed/early-stage VC that has co-invested with Compound in SuppCo. It is comparable as a thesis-led investment firm focused on early-stage technical founders, though operating across a broader category set than Compound.

TypeBroad incumbent
Description

Box Group is a thesis-driven early-stage VC and a confirmed co-investor alongside Compound (in SuppCo). It is comparable as a similarly-sized thesis-led, content-publishing firm investing in deep-tech and crypto categories.

TypeDirect peer
Description

Arch Venture Partners is a thesis-driven deep-tech and biotech VC with deep domain expertise and specialist partners. It overlaps with Compound's biology/biotech thesis category and its emphasis on technically deep, science-first investing.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment275 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Compound

Venture Capitalcompound.vc

Compound is a New York-based, thesis-driven venture capital firm investing across AI/ML, biology, crypto, and robotics. It serves technical founders with capital and specialist Venture Partner support, publishes 100+ public investment theses, and operates a non-dilutive micro-grants program.

What Compound does

Compound is a thesis-driven, research-centric venture capital firm founded in 2016 and headquartered at 414 Broadway, New York. The firm invests across six explicit thesis categories—AI/ML, Healthcare, Bio, Robotics, Crypto, and Other—and targets technical founders who require both capital and credible domain engagement. Its 11-person team comprises Managing Partner Michael Dempsey, General Partner David Hirsch, CFO Tara Eckert, Partners 0xSmac and Shelby Newsad, Researcher Mackenzie Morehead, and five Venture Partners covering computational biology, data science & AI, biology, crypto, and AI & robotics.

Compound's core offering is research-driven deal-making, publicised through a Notion-hosted Thesis Database of 100+ investment theses and a content engine spanning the Compound Writing page, CompoundArxiv on Twitter/X, Substack newsletters, and a dedicated crypto sub-site (crypto.compound.vc). The firm uses this corpus as both internal investment framework and external marketing surface, positioning itself to attract founders whose work aligns with pre-published theses. Its business model is that of a small venture fund: economics flow from management fees and carried interest on invested capital, with deal flow sourced from public theses, syndication networks, and direct founder outreach.

Disclosed portfolio activity includes co-investments in SuppCo ($5.5M seed, October 2024) alongside Union Square Ventures, True Ventures, and Box Group; Cycles ($6.4M seed, May 2026) alongside Blockchange Ventures, Coinbase Ventures, and Primitive Ventures; and Orbital Industries ($50M Series B, May 2026) alongside Plural, NVentures (NVIDIA), Radical Ventures, and Fly Ventures. In 2026 the firm extended its research ethos outward via Compound Reverie Grants, a non-dilutive micro-grant program offering $500–$7,500 to researchers in machine learning, robotics, biology, healthcare, energy, and crypto. No firm-level AUM, fund size, or revenue figures are disclosed.

Compound firmographics

Firmographics
Name
Compound
Legal name
Compound
Website
https://compound.vc
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Compound is a New York-based, thesis-driven venture capital firm investing across AI/ML, biology, crypto, and robotics. It serves technical founders with capital and specialist Venture Partner support, publishes 100+ public investment theses, and operates a non-dilutive micro-grants program.
Ownership category
akta.pro rank

Compound industry classification

Industry
Product category
Venture Capital
NAICS
Other Investment Pools and Funds (5259), Portfolio Management and Investment Advice (523940)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAB
Early-Stage Venture Capital (Series A/B)
SECONDARYFSANAJAN
SDG / Thematic Sustainable Investment Funds
Financial & Insurance/Private Equity & Venture Capital/Impact / ESG & Sustainable Investment Funds

Keywords

  • Thesis-driven venture capital
  • Deep tech investing
  • Early-stage startup funding
  • Crypto venture capital
  • Biology biotech investing

Where Compound is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Compound business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Investment fund returns: As a thesis-driven venture investment firm, Compound generates economic returns (and fund-level revenue) through capital deployment into portfolio companies and co-investments alongside other investors. Specific fund economics (management fees, carried interest) are not publicly disclosed.
  2. Reverie Grants program (outbound capital): Outbound grant capital of $500 to $7,500 to researchers in cryonics, life extension, AGI safety, mind uploading; not a revenue stream but a capital deployment activity tied to thesis exploration.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goReverie Grants ($500 - $7,500)

Go-to-market motion3 records

Distribution channels2 records

Marketing channels6 records

Compound product offering

Product offering

Core offering

Compound is a thesis-driven, research-centric venture capital investment firm that deploys capital into early-stage companies across six categories (AI/ML, Healthcare, Biology, Robotics, Crypto, and Other). It supports founders with domain expertise from specialist Venture Partners, publishes 100+ public investment theses via its Thesis Database and Writing platform, and operates the Compound Reverie Grants micro-grant program ($500–$7,500) for thesis-aligned and transitional researchers.

Product overview

Compound operates as a unified thesis-driven, research-centric investment firm rather than a traditional multi-product software platform; its public surface area consists of seven interconnected web properties that together form the firm's offering: the Compound Home landing page introducing the firm; the About Us team and mission page; the public Portfolio showcase across Automation (AI/ML/Robotics), Healthcare & Biology, Crypto, and Other categories; the Writing publication platform with essays authored by team members; the standalone Compound Thesis Database of 100 publicly available theses across six categories; the Compound Reverie Grants micro-grant program providing non-dilutive funding to edge-of-thesis explorers; and the Compound Crypto sub-site at crypto.compound.vc for crypto-focused content. The modules fit together as a stack in which the Home/About pages anchor the firm's positioning, the Portfolio demonstrates execution on those beliefs, the Writing and Thesis Database publish the underlying research, the Crypto sub-site drills into one of the six thesis categories, and Reverie Grants extends the firm's research ethos outward to non-venture grantees.

Differentiator

Problem solved

Functional benefit

Brands

  • Compound Reverie Grants: Micro-grants program offering $500–$7,500 in non-dilutive funding for exploratory, thesis-aligned and transitional projects.
  • Compound Crypto

Products and services

  • Compound Reverie Grants Micro-grant program offering non-dilutive, no-strings-attached funding of $500 to $7,500 to individual researchers and transitional thinkers exploring ideas at the edges of the firm's thesis areas, including machine learning, robotics, biology, healthcare, energy, crypto, cryonics, life extension, AGI safety, and mind uploading.
  • Thesis-Driven Venture Capital Investment Capital deployment into early-stage companies across six thesis categories (AI/ML, Healthcare, Biology, Robotics, Crypto, Other), paired with technical co-building from specialist Venture Partners who help founders solve technical problems, communicate breakthroughs, and scale commercialization.

Quantifiable outcome

  • 100+ public theses published across 6 categories since 2016
  • +2 more outcomes

Companies that use Compound

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Compound technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Compound partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Compound competitors and assessment

Company assessment

Direct peers

  • Paradigm: Paradigm is a thesis-driven crypto/web3-focused investment firm that publishes research and operates with deep domain expertise. It is the closest comparable to Compound's crypto thesis-led, research-publishing model and overlapping crypto portfolio (e.g., investments in Arbitrum-adjacent infrastructure).
  • Lux Capital: Lux Capital is a thesis-driven deep-tech VC investing in AI, robotics, biology, and frontier science with published research and a specialist partner model. It is directly comparable to Compound's bio/AI/robotics thesis-led approach and emphasis on scientifically deep founders.
  • DCVC: DCVC (Data Collective) is a thesis-driven deep-tech VC that publishes deep research and invests in computational biology, AI, and engineering biology. It mirrors Compound's six-category, science-first thesis approach and its co-investor posture alongside tier-1 VCs.
  • Arch Venture Partners: Arch Venture Partners is a thesis-driven deep-tech and biotech VC with deep domain expertise and specialist partners. It overlaps with Compound's biology/biotech thesis category and its emphasis on technically deep, science-first investing.

Emerging players

  • Outset Capital: Outset Capital is an emerging thesis-driven, research-publishing AI investment firm. It overlaps with Compound's AI/ML & Robotics thesis category and similarly publishes public research as a deal-sourcing and brand-building tool, though at an earlier stage.

Broad incumbents

  • Founders Fund: Founders Fund is a thesis-driven, broad-spectrum VC that publishes essays and bold theses to attract founders. It is comparable to Compound as a thesis-led, content-forward investment firm, but at a much larger scale and across a wider category set.
  • Andreessen Horowitz (a16z): a16z is a broad incumbent thesis-driven VC with a dedicated crypto fund (a16z crypto) that publishes extensive research and operates large grant programs. It overlaps with Compound's crypto thesis category and content-led GTM, but at vastly greater scale and with a multi-stage, multi-product platform.
  • Union Square Ventures: USV is a thesis-driven VC investing across crypto, consumer, and frontier tech, and is a confirmed co-investor with Compound (led SuppCo). It is comparable as a fellow thesis-led, content-publishing VC firm that participates in similar categories like crypto and consumer health.
  • True Ventures: True Ventures is a thesis-driven seed/early-stage VC that has co-invested with Compound in SuppCo. It is comparable as a thesis-led investment firm focused on early-stage technical founders, though operating across a broader category set than Compound.
  • Box Group: Box Group is a thesis-driven early-stage VC and a confirmed co-investor alongside Compound (in SuppCo). It is comparable as a similarly-sized thesis-led, content-publishing firm investing in deep-tech and crypto categories.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights6 records

Customer concentration

Compound social profiles

Digital presence

Compound financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Compound leadership team

Management profile

Number of profiles

Profiles11 records

Compound subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Compound funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Compound M&A and investment

M&A and investment

M&A

Investments275 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Compound

What does Compound do?

Compound is a thesis-driven, research-centric venture capital investment firm that deploys capital into early-stage companies across six categories (AI/ML, Healthcare, Biology, Robotics, Crypto, and Other). It supports founders with domain expertise from specialist Venture Partners, publishes 100+ public investment theses via its Thesis Database and Writing platform, and operates the Compound Reverie Grants micro-grant program ($500–$7,500) for thesis-aligned and transitional researchers.

Is Compound a public or private company?

Compound is a private company. It is classified as management employee owned and is currently operating.

When was Compound founded?

Compound was founded in 2016. It employs 11 to 50 people.

Where is Compound based?

Compound is headquartered in New York, United States, in the North America region.

How does Compound make money?

Two revenue lines are on record. Investment fund returns are the primary driver. The others are reverie Grants program (outbound capital).

Who are Compound's main competitors?

Direct peers on record are Paradigm, Lux Capital, DCVC and Arch Venture Partners. Outset Capital is listed as an emerging player. Broad incumbents are Founders Fund, Andreessen Horowitz (a16z), Union Square Ventures, True Ventures and Box Group.

Does Compound have an API?

No public API is recorded for Compound.

What industry is Compound in?

Compound's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B), with a secondary code of FSANAJAN, SDG / Thematic Sustainable Investment Funds. Its NAICS code is 5259 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TradingViewCrypto Venture Capital Effectively Stalled as Talent, Capital Shift to AICrypto venture capital has stalled for about two years, with talent and capital shifting to AI. Michael Dempsey of Compound, managing over $200 million, said tech founders moved to crypto in 2021 but now favor AI. He noted token-based compensation struggles to align long-term incentives.Crypto BriefingCrypto venture capital struggles as AI attracts talent, says Compound’s DempseyCompound managing partner Michael Dempsey said crypto venture activity has been nearly dormant for two years, as AI has drawn both talent and capital away. He noted token incentives have struggled to deliver long-term alignment, and the slowdown may signal investor caution toward projects with stronger fundamentals.链捕手 ChainCatcherMichael Dempsey:加密风投近两年几乎停滞,人才流向 AIMichael Dempsey, managing partner of Compound, said crypto venture capital has nearly stagnated over the past two years, with talent shifting to AI. He noted fewer entrepreneurs are willing to engage in crypto, and token incentives are not conducive to long-term incentives. He also pointed out that some distributed tokens are showing actual value.链捕手 ChainCatcherMichael Dempsey: Cryptocurrency venture...Michael Dempsey, managing partner at Compound, said cryptocurrency venture capital has nearly stagnated over the past two years, with talent shifting to AI. He noted fewer entrepreneurs are willing to engage in crypto, and token incentives are not conducive to long-term incentives. He suggested some distributed tokens show real value, but few new DEX projects are emerging.AlleyWatchThe New York Tech Daily Funding Report: 11/6/2026Cowboy, an AI app store for developers, raised $5M in seed funding from investors including Nebular, Compound, and Semantic Ventures. The company was founded by Chad DePue in 2025.VC News DailyCowboy Closes $5 Million in Seed FundingCowboy, an AI app store, emerged from stealth with $5 million in seed funding. The platform lets developers own, control, and monetize AI, offering over 10,000 agents, data feeds, skills, and models. Investors include Nebular, Compound, and Semantic Ventures.FinSMEsCowboy Raises $5M in FundingCowboy, a NYC-based AI app store platform, raised $5M in funding from backers including Nebular, Compound, and others. The company plans to use the funds to expand its platform and operations, which hosts over 100 agents and 10,000 data feeds.DataCentreNews UKOrbital raises USD $50 million to scale data centresOrbital Industries has raised USD $50 million in a Series B funding round led by Plural, with participation from NVentures (Nvidia's venture arm), Radical Ventures, Compound, and Fly Ventures. The London-based company develops hardware for AI infrastructure, including a modular data centre system that reduces deployment times to six months compared with three years for conventional projects, and a dielectric two-phase cooling fluid for GPUs that is non-toxic and free from PFAS. The funding will support wider commercial deployment of Orbital's data centre products, hiring in London and San Francisco, and the company is also working with AWS on cooling and efficiency technologies for hyperscale facilities.Pulse 2.0Orbital Industries: $50 Million Series B Raised To Scale AI Engine For The Physical Economy And Data Centre HardwareOrbital Industries raised $50 million in Series B funding led by Plural, with participation from NVentures (NVIDIA), Radical Ventures, Compound, and Fly Ventures, to scale deployment of data centre infrastructure products and expand its AI and engineering teams across London and San Francisco. The company has developed a dielectric cooling fluid for next-generation GPUs that avoids PFAS chemicals, and holds a multi-year partnership with AWS focused on cooling and efficiency technologies for hyperscale data centres. Orbital Industries plans to apply its AI-driven industrial development model across additional sectors including semiconductors, critical minerals, aerospace, and energy.EU-StartupsLondon’s Orbital Industries bags €43 million to build industrial hardware from the atoms upOrbital Industries, a British AI industrial hardware company, has raised €43 million in Series B funding led by Plural, with participation from NVentures (NVIDIA), Radical Ventures, Compound, and Fly Ventures, to scale data centre products, expand its AI and engineering teams, and develop its platform for industrial applications. The company has developed a dielectric cooling fluid free from PFAS "forever chemicals" and a modular data centre system that can be deployed in six months compared to traditional timelines of up to three years, and has a multi-year partnership with AWS to develop cooling and efficiency technologies for hyperscale data centres. Orbital Industries aims to apply its AI-driven approach, using its Orb quantum mechanical simulation engine, across sectors including semiconductors, critical minerals, aerospace and energy.